• Something wrong with this record ?

The impact of graphene oxide on androgen receptor signalling in prostate cancer cells

O. Ženata, A. Panáček, L. Kvítek, R. Vrzal

. 2021 ; 269 (-) : 128759. [pub] 20201030

Language English Country Great Britain

Document type Journal Article

Androgen receptor (AR) signalling is triggered by androgens that have lipophilic nature. Since it was indicated that graphene oxide (GO) might facilitate passive diffusion of lipophilic compounds probably via Trojan horse-like mechanism, we tested the hypothesis if this suggestion would apply for androgens as well. Thus, we investigated if GO affects dihydrotestosterone (DHT)-triggered signalling of AR in two prostate cancer-derived cell lines, 22Rv1 and LNCaP. These cell lines differ in number of AR variants, i.e. there are two variants in 22Rv1 cells (full length and truncated) but only one in LNCaP cells (full length). Graphene oxide had no effect on basal luciferase activity but significantly decreased DHT-inducible AR-dependent luciferase activity in stably transfected cells. In 22Rv1 cells, it induced concentration-dependent decrease of DHT-inducible KLK3 mRNA and PSA protein after 24 h. While there was no effect on UBE2C mRNA (regulated by truncated variant), there was synergistic effect of DHT and GO on UBE2C protein level. Translocation of full-length AR (AR-FL) was potentiated by GO in the presence of DHT in 22Rv1 cells but it was suppressed in LNCaP cells. DHT-stimulated enrichment of AR-FL on KLK3 promoter was not significantly affected by GO in any tested cell line neither was KLK3 mRNA at 4 h of incubation. In conclusion, GO affects DHT-triggered signalling in both types of cells in similar manner, but ligand-triggered redistribution of AR-FL is affected differently. One of the reasons may be the presence of truncated variant of androgen receptor.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21011400
003      
CZ-PrNML
005      
20210507102351.0
007      
ta
008      
210420s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.chemosphere.2020.128759 $2 doi
035    __
$a (PubMed)33153849
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Ženata, Ondřej $u Department of Cell Biology and Genetics, Faculty of Science, Palacky University in Olomouc, Slechtitelu 27, Olomouc, CZ-783 71, Czech Republic
245    14
$a The impact of graphene oxide on androgen receptor signalling in prostate cancer cells / $c O. Ženata, A. Panáček, L. Kvítek, R. Vrzal
520    9_
$a Androgen receptor (AR) signalling is triggered by androgens that have lipophilic nature. Since it was indicated that graphene oxide (GO) might facilitate passive diffusion of lipophilic compounds probably via Trojan horse-like mechanism, we tested the hypothesis if this suggestion would apply for androgens as well. Thus, we investigated if GO affects dihydrotestosterone (DHT)-triggered signalling of AR in two prostate cancer-derived cell lines, 22Rv1 and LNCaP. These cell lines differ in number of AR variants, i.e. there are two variants in 22Rv1 cells (full length and truncated) but only one in LNCaP cells (full length). Graphene oxide had no effect on basal luciferase activity but significantly decreased DHT-inducible AR-dependent luciferase activity in stably transfected cells. In 22Rv1 cells, it induced concentration-dependent decrease of DHT-inducible KLK3 mRNA and PSA protein after 24 h. While there was no effect on UBE2C mRNA (regulated by truncated variant), there was synergistic effect of DHT and GO on UBE2C protein level. Translocation of full-length AR (AR-FL) was potentiated by GO in the presence of DHT in 22Rv1 cells but it was suppressed in LNCaP cells. DHT-stimulated enrichment of AR-FL on KLK3 promoter was not significantly affected by GO in any tested cell line neither was KLK3 mRNA at 4 h of incubation. In conclusion, GO affects DHT-triggered signalling in both types of cells in similar manner, but ligand-triggered redistribution of AR-FL is affected differently. One of the reasons may be the presence of truncated variant of androgen receptor.
650    _2
$a androgeny $7 D000728
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a dihydrotestosteron $x farmakologie $7 D013196
650    _2
$a grafit $7 D006108
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    12
$a nádory prostaty $7 D011471
650    12
$a androgenní receptory $x genetika $7 D011944
655    _2
$a časopisecké články $7 D016428
700    1_
$a Panáček, Aleš $u Regional Centre of Advanced Technologies and Materials, Department of Physical Chemistry, Faculty of Science, Palacky University in Olomouc, 17. Listopadu 12, 771 46, Olomouc, Czech Republic
700    1_
$a Kvítek, Libor $u Regional Centre of Advanced Technologies and Materials, Department of Physical Chemistry, Faculty of Science, Palacky University in Olomouc, 17. Listopadu 12, 771 46, Olomouc, Czech Republic
700    1_
$a Vrzal, Radim $u Department of Cell Biology and Genetics, Faculty of Science, Palacky University in Olomouc, Slechtitelu 27, Olomouc, CZ-783 71, Czech Republic. Electronic address: radim.vrzal@email.cz
773    0_
$w MED00002124 $t Chemosphere $x 1879-1298 $g Roč. 269, č. - (2021), s. 128759
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33153849 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20210507102350 $b ABA008
999    __
$a ok $b bmc $g 1649941 $s 1131779
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 269 $c - $d 128759 $e 20201030 $i 1879-1298 $m Chemosphere $n Chemosphere $x MED00002124
LZP    __
$a Pubmed-20210420

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...